Akero Therapeutics Inc (AKRO)
21.93
-0.45
(-2.01%)
USD |
NASDAQ |
Jul 03, 16:00
21.95
+0.02
(+0.09%)
Pre-Market: 08:32
Akero Therapeutics 30-Day Average Daily Volume: 935608.2 for July 3, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| July 03, 2024 | 935608.2 |
| July 02, 2024 | 947658.6 |
| July 01, 2024 | 948483.2 |
| June 28, 2024 | 941157.6 |
| June 27, 2024 | 833218.4 |
| June 26, 2024 | 838040.3 |
| June 25, 2024 | 830076.3 |
| June 24, 2024 | 832620.5 |
| June 21, 2024 | 827766.8 |
| June 20, 2024 | 760135.5 |
| June 18, 2024 | 759337.7 |
| June 17, 2024 | 766002.0 |
| June 14, 2024 | 756920.2 |
| June 13, 2024 | 752927.1 |
| June 12, 2024 | 768607.3 |
| June 11, 2024 | 753753.2 |
| June 10, 2024 | 739495.2 |
| June 07, 2024 | 732832.3 |
| June 06, 2024 | 709013.6 |
| June 05, 2024 | 699291.4 |
| June 04, 2024 | 667265.8 |
| June 03, 2024 | 659265.5 |
| May 31, 2024 | 666704.3 |
| May 30, 2024 | 667751.0 |
| May 29, 2024 | 662080.3 |
| Date | Value |
|---|---|
| May 28, 2024 | 674452.6 |
| May 24, 2024 | 666133.3 |
| May 23, 2024 | 661899.9 |
| May 22, 2024 | 650660.9 |
| May 21, 2024 | 656707.3 |
| May 20, 2024 | 657725.6 |
| May 17, 2024 | 650197.6 |
| May 16, 2024 | 652669.4 |
| May 15, 2024 | 665718.5 |
| May 14, 2024 | 671066.4 |
| May 13, 2024 | 679197.0 |
| May 10, 2024 | 683025.2 |
| May 09, 2024 | 692497.3 |
| May 08, 2024 | 711711.6 |
| May 07, 2024 | 721579.4 |
| May 06, 2024 | 729389.2 |
| May 03, 2024 | 750329.3 |
| May 02, 2024 | 767806.0 |
| May 01, 2024 | 805241.4 |
| April 30, 2024 | 808447.6 |
| April 29, 2024 | 829697.8 |
| April 26, 2024 | 986098.8 |
| April 25, 2024 | 1.069M |
| April 24, 2024 | 1.088M |
| April 23, 2024 | 1.116M |
30-Day Average Daily Volume Range, Past 5 Years
67516.83
Minimum
Nov 18 2019
2.900M
Maximum
Nov 20 2023
548359.4
Average
264997.0
Median
Aug 15 2022
30-Day Average Daily Volume Benchmarks
| Madrigal Pharmaceuticals Inc | 535764.0 |
| Savara Inc | 2.503M |
| Aldeyra Therapeutics Inc | 358667.7 |
| Viking Therapeutics Inc | 3.911M |
| 89bio Inc | 1.273M |